Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Indoles »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Indoleamine-Pyrrole 2,3,-Dioxygenase < Indoles < Indomethacin  Facettes :

List of bibliographic references indexed by Indoles

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000941 (2014) Thomas J. Moore [États-Unis] ; Joseph Glenmullen [États-Unis] ; Donald R. Mattison [Canada]Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
000A37 (2014) Plamena R. Angelova [Canada] ; Bikram Keshari Agrawalla ; Pia A. Elustondo ; Jacob Gordon ; Toshikazu Shiba ; Andrey Y. Abramov ; Young-Tae Chang ; Evgeny V. PavlovIn situ investigation of mammalian inorganic polyphosphate localization using novel selective fluorescent probes JC-D7 and JC-D8.
001A31 (2010) Daniel Weintraub [États-Unis] ; Juergen Koester ; Marc N. Potenza ; Andrew D. Siderowf ; Mark Stacy ; Valerie Voon ; Jacqueline Whetteckey ; Glen R. Wunderlich ; Anthony E. LangImpulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
002C01 (2004) Alan L. Whone [Royaume-Uni] ; Dale L. Bailey ; Philippe Remy ; Nicola Pavese ; David J. BrooksA technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.
002D10 (2004) Ajmal Razmy [Canada] ; Anthony E. Lang [Canada] ; Colin M. Shapiro [Canada]Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists
002F43 (2003) Michael Iskedjian [Canada] ; Thomas R. Einarson [Canada]Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease
002F45 (2003) Mahyar Etminan [Canada] ; Sudeep Gill [Canada] ; Ali Samii [États-Unis]Comparison of the risk of adverse events with Pramipexole and ropinirole in patients with Parkinson's disease a meta-analysis
003122 (2001) H. MollerAntiparkinsonian drugs and "sleep attacks".
003310 (2001) Mahyar Etminan [Canada] ; Ali Samii [États-Unis] ; Bahi Takkouche [Espagne] ; Paula A. Rochon [Canada]Increased risk of somnolence with the new dopamine agonists in Patients with Parkinson's disease: A meta-analysis of randomised controlled trials
003801 (1999) D. E. Hobson [Canada] ; E. Pourcher [Canada] ; W. R. W. Martin [Canada]Ropinirole and pramipexole, the new agonists
003C96 (1996) J P Doucet [Canada] ; Y. Nakabeppu ; P J Bedard ; B T Hope ; E J Nestler ; B J Jasmin ; J S Chen ; M J Iadarola ; M. St-Jean ; N. Wigle ; P. Blanchet ; R. Grondin ; G S RobertsonChronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
003F76 (1995) Céline Gagnon [Canada] ; Baltazar Gomez-Mancilla [Canada] ; Rudolf Markstein [Suisse] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of adding the D-1 agonist CY 208–243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors
004453 (1993) B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. BedardEffect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors
004459 (1993) C. Gagnon [Canada] ; B. Gomez-Mancilla ; P. J. Bedard ; T. Di Paolo [Canada]Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors
004526 (1992) Baltazar Gomez-Mancilla [Canada] ; Paul J. Bédard [Canada]Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys
004585 (1992) Baltazar Gomez-Mancilla [Canada] ; René Boucher [Canada] ; René Bédard [Canada]Effect of LY 171555 and CY 208‐243 on tremor suppression in the MPTP monkey model of parkinsonism
004B42 (1989) J. K. C. Tsui ; E. C. Wolters ; R. F. Peppard ; D. B. CalneA double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Indoles" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Indoles" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Indoles
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022